WCG Unveils Strategic Alliance Program for CROs
WCG has launched a program to augment the existing capabilities of CROs and further support the work they do in driving innovation in clinical trials. By providing CROs with access to its clinical trial operations data, the WCG CRO Strategic Alliance Program enables CROs to better serve patients and research sponsors, and accelerate the pace at which new therapies are brought to market.
Read more about this new alliance program here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
